Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH)’s stock price has dropped by -13.55 in relation to previous closing price of 0.43. Nevertheless, the company has seen a loss of -23.66% in its stock price over the last five trading days. globenewswire.com reported 2025-03-13 that GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the closing of its previously announced underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (the “Offering”). The aggregate gross proceeds to Shuttle Pharma from the Offering was approximately $5.75 million, before deducting underwriting discounts and commissions and other offering expenses payable by Shuttle Pharma.
Is It Worth Investing in Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) Right Now?
The 36-month beta value for SHPH is also noteworthy at 0.49.
The public float for SHPH is 3.29M, and at present, short sellers hold a 1.28% of that float. The average trading volume of SHPH on March 17, 2025 was 122.19K shares.
SHPH’s Market Performance
SHPH’s stock has seen a -23.66% decrease for the week, with a -46.39% drop in the past month and a -50.60% fall in the past quarter. The volatility ratio for the week is 23.83%, and the volatility levels for the past 30 days are at 14.55% for Shuttle Pharmaceuticals Holdings Inc The simple moving average for the last 20 days is -33.09% for SHPH’s stock, with a simple moving average of -78.24% for the last 200 days.
SHPH Trading at -47.69% from the 50-Day Moving Average
After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.15% of loss for the given period.
Volatility was left at 14.55%, however, over the last 30 days, the volatility rate increased by 23.83%, as shares sank -46.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -52.13% lower at present.
During the last 5 trading sessions, SHPH fell by -23.66%, which changed the moving average for the period of 200-days by -88.85% in comparison to the 20-day moving average, which settled at $0.5530. In addition, Shuttle Pharmaceuticals Holdings Inc saw -56.93% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SHPH
The total capital return value is set at -7.91. Equity return is now at value -383.84, with -216.24 for asset returns.
Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at -6.24. The debt to equity ratio resting at 1.65. The interest coverage ratio of the stock is -5.66.
Currently, EBITDA for the company is -7.7 billion with net debt to EBITDA at 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
In summary, Shuttle Pharmaceuticals Holdings Inc (SHPH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
